11 results on '"Flanagan, Katie L."'
Search Results
2. Sex differences in immune responses.
- Author
-
Klein SL and Flanagan KL
- Subjects
- Adaptive Immunity, Age Factors, Animals, Disease Susceptibility, Environment, Female, Gene-Environment Interaction, Genetic Variation, Hormones, Humans, Immunity, Innate, Male, Reproduction genetics, Reproduction immunology, Immunity genetics, Immunity immunology, Sex Factors
- Abstract
Males and females differ in their immunological responses to foreign and self-antigens and show distinctions in innate and adaptive immune responses. Certain immunological sex differences are present throughout life, whereas others are only apparent after puberty and before reproductive senescence, suggesting that both genes and hormones are involved. Furthermore, early environmental exposures influence the microbiome and have sex-dependent effects on immune function. Importantly, these sex-based immunological differences contribute to variations in the incidence of autoimmune diseases and malignancies, susceptibility to infectious diseases and responses to vaccines in males and females. Here, we discuss these differences and emphasize that sex is a biological variable that should be considered in immunological studies.
- Published
- 2016
- Full Text
- View/download PDF
3. Sexual dimorphism in biomedical research: a call to analyse by sex.
- Author
-
Flanagan KL
- Subjects
- Chromosomes, Human, X physiology, Female, Humans, Male, Sex Chromosomes physiology, Biomedical Research methods, Immunity physiology, Sex Characteristics
- Published
- 2014
- Full Text
- View/download PDF
4. COVID‐19 vaccination: are more jabs needed or are we now immune?
- Author
-
Giles, Michelle L. and Flanagan, Katie L.
- Subjects
- *
MEDICAL protocols , *IMMUNIZATION , *T cells , *IMMUNOGLOBULINS , *HEALTH policy , *COVID-19 vaccines , *COMBINED vaccines , *RNA , *CORONAVIRUS spike protein , *ANTIBODY formation , *GENETIC mutation , *COVID-19 , *IMMUNITY - Abstract
As the COVID‐19 pandemic has progressed, it has become apparent that COVID‐19 vaccination has limited impact on SAR‐CoV‐2 transmission and provides only short‐term protection against acquiring infection, but more robust protection against severe disease and death. As a result, vaccinated people remain susceptible to SARS‐CoV‐2 infection but are less likely to experience severe outcomes. Studies show that immunity derived from the combination of vaccination and natural infection, so‐called hybrid immunity, is superior to that provided by vaccination or natural infection alone. Since most Australian adults have received three or more doses of COVID‐19 vaccines and >70% have also been infected with SARS‐CoV‐2, we now have a population with high levels of hybrid immunity. This was mostly achieved by receiving original Wuhan strain vaccines and then experiencing Omicron strain infections. The original Wuhan strain of SARS‐CoV‐2 has now disappeared and been replaced with Omicron‐lineage variants globally. The predominance of the Omicron strain initially led to the development of bivalent vaccines containing both the Wuhan strain and Omicron variants. Currently, vaccines containing the original Wuhan strain of spike protein are being phased out, and new COVID‐19 vaccines based exclusively on the Omicron strain XBB have become available in Australia. This article explores the question of whether further doses will be required from 2024 onwards and, if so, who should receive them? [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Potent Induction of Focused Th1-Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a Recombinant Plasmodium falciparum Malaria Vaccine
- Author
-
Lalvani, Ajit, Moris, Phillipe, Voss, Gerald, Pathan, Ansar A., Kester, Kent E., Brookes, Roger, Lee, Edwin, Koutsoukos, Marguerite, Plebanski, Magdalena, Delchambre, Martine, Flanagan, Katie L., Carton, Cecile, Slaoui, Moncef, Van Hoecke, Christian, Ballou, W. Ripley, Hill, Adrian V. S., and Cohen, Joe
- Published
- 1999
6. Neonatal BCG Vaccination Reduces Interferon-γ Responsiveness to Heterologous Pathogens in Infants From a Randomized Controlled Trial.
- Author
-
Freyne, Bridget, Messina, Nicole L, Donath, Susan, Germano, Susie, Bonnici, Rhian, Gardiner, Kaya, Casalaz, Dan, Robins-Browne, Roy M, Netea, Mihai G, Flanagan, Katie L, Kollmann, Toby, Curtis, Nigel, Group, Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), Freyne, B, Messina, N L, Donath, S, Germano, S, Bonnici, R, Gardiner, K, and Casalaz, D
- Subjects
BCG vaccines ,RANDOMIZED controlled trials ,INFANTS ,INTERFERON gamma ,TOLL-like receptors ,BACTERIAL disease prevention ,RESEARCH ,IMMUNIZATION ,AGE distribution ,RESEARCH methodology ,EVALUATION research ,MEDICAL cooperation ,INTERFERONS ,MEDICAL protocols ,TREATMENT effectiveness ,COMPARATIVE studies ,IMMUNITY ,BACTERIAL diseases ,LONGITUDINAL method - Abstract
Background: BCG vaccination has beneficial nonspecific (heterologous) effects that protect against nonmycobacterial infections. We have previously reported that BCG vaccination at birth alters in vitro cytokine responses to heterologous stimulants in the neonatal period. This study investigated heterologous responses in 167 infants in the same trial 7 months after randomization.Methods: A whole-blood assay was used to interrogate in vitro cytokine responses to heterologous stimulants (killed pathogens) and Toll-like receptor (TLR) ligands.Results: Compared to BCG-naive infants, BCG-vaccinated infants had increased production of interferon gamma (IFN-γ) and monokine induced by gamma interferon (MIG) (CXCL9) in response to mycobacterial stimulation and decreased production of IFN-γ in response to heterologous stimulation and TLR ligands. Reduced IFN-γ responses were attributable to a decrease in the proportion of infants who mounted a detectable IFN-γ response. BCG-vaccinated infants also had increased production of MIG (CXCL9) and interleukin-8 (IL-8), and decreased production of IL-10, macrophage inflammatory protein-1α (MIP-1α), and MIP-1β, the pattern of which varied by stimulant. IL-1Ra responses following TLR1/2 (Pam3CYSK4) stimulation were increased in BCG-vaccinated infants. Both sex and maternal BCG vaccination status influenced the effect of neonatal BCG vaccination.Conclusions: BCG vaccination leads to changes in IFN-γ responsiveness to heterologous stimulation. BCG-induced changes in other cytokine responses to heterologous stimulation vary by pathogen. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
7. Effect of sex on vaccination outcomes: important but frequently overlooked.
- Author
-
Harper, Alice and Flanagan, Katie L
- Subjects
- *
VACCINATION , *IMMUNOGLOBULINS , *IMMUNITY , *TREATMENT effectiveness , *T cells - Abstract
It is well established that vaccination does not affect males and females equally. For example, females generally mount greater antibody responses to vaccination than males, but also suffer more adverse events following vaccination, probably as a result of more robust immunity. Despite this, most researchers in the field of vaccinology do not take biological sex into account when conducting their studies. This omission is likely to lead to a loss of important information in terms of both reactogenicity and immunogenicity following vaccination as well as those suffering adverse events. It also suggests that the vaccine dose in males and females may need to be different in order to achieve the same outcome of protective immunity while minimising reactogenicity. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
8. Age-Dependent Maturation of Toll-Like Receptor-Mediated Cytokine Responses in Gambian Infants.
- Author
-
Burl, Sarah, Townend, John, Njie-Jobe, Jainaba, Cox, Momodou, Adetifa, Uche J., Touray, Ebrima, Philbin, Victoria J., Mancuso, Christy, Kampmann, Beate, Whittle, Hilton, Jaye, Assan, Flanagan, Katie L., and Levy, Ofer
- Subjects
CYTOKINES ,ONTOGENY ,LEUCOCYTES ,INFANT diseases ,IMMUNITY ,VACCINES ,IMMUNIZATION of children - Abstract
The global burden of neonatal and infant mortality due to infection is staggering, particularly in resource-poor settings. Early childhood vaccination is one of the major interventions that can reduce this burden, but there are specific limitations to inducing effective immunity in early life, including impaired neonatal leukocyte production of Th1-polarizing cytokines to many stimuli. Characterizing the ontogeny of Toll-like receptor (TLR)-mediated innate immune responses in infants may shed light on susceptibility to infection in this vulnerable age group, and provide insights into TLR agonists as candidate adjuvants for improved neonatal vaccines. As little is known about the leukocyte responses of infants in resource-poor settings, we characterized production of Th1-, Th2-, and anti-inflammatory- cytokines in response to agonists of TLRs 1-9 in whole blood from 120 Gambian infants ranging from newborns (cord blood) to 12 months of age. Most of the TLR agonists induced TNFα, IL-1β, IL-6, and IL-10 in cord blood. The greatest TNFα responses were observed for TLR4, -5, and -8 agonists, the highest being the thiazoloquinoline CLO75 (TLR7/8) that also uniquely induced cord blood IFNγ production. For most agonists, TLR-mediated TNFα and IFNγ responses increased from birth to 1 month of age. TLR8 agonists also induced the greatest production of the Th1-polarizing cytokines TNFα and IFNγ throughout the first year of life, although the relative responses to the single TLR8 agonist and the combined TLR7/8 agonist changed with age. In contrast, IL-1β, IL-6, and IL-10 responses to most agonists were robust at birth and remained stable through 12 months of age. These observations provide fresh insights into the ontogeny of innate immunity in African children, and may inform development of agespecific adjuvanted vaccine formulations important for global health. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
9. Correlation of Memory T Cell Responses against TRAP with Protection from Clinical Malaria, and CD4+ CD25high T Cells with Susceptibility in Kenyans.
- Author
-
Todryk, Stephen M., Bejon, Philip, Mwangi, Tabitha, Plebanski, Magdalena, Urban, Britta, Marsh, Kevin, Hill, Adrian V. S., and Flanagan, Katie L.
- Subjects
T cells ,MALARIA ,DISEASE susceptibility ,IMMUNITY ,VACCINATION ,ERYTHROCYTES ,ANTIGENS ,KILLER cells - Abstract
Background: Immunity to malaria develops naturally in endemic regions, but the protective immune mechanisms are poorly understood. Many vaccination strategies aim to induce T cells against diverse pre-erythrocytic antigens, but correlates of protection in the field have been limited. The objective of this study was to investigate cell-mediated immune correlates of protection in natural malaria. Memory T cells reactive against thrombospondin-related adhesive protein (TRAP) and circumsporozoite (CS) protein, major vaccine candidate antigens, were measured, as were frequencies of CD4
+ CD25high T cells, which may suppress immunity, and CD56+ NK cells and γδ T cells, which may be effectors or may modulate immunity. Methodology and Principal Findings: 112 healthy volunteers living in rural Kenya were entered in the study. Memory T cells reactive against TRAP and CS were measured using a cultured IFNc ELISPOT approach, whilst CD4+ CD25high T cells, CD56+ NK cells, and γδ T cells were measured by flow cytometry. We found that T cell responses against TRAP were established early in life (<5 years) in contrast to CS, and cultured ELISPOT memory T cell responses did not correlate with ex-vivo IFNγ ELISPOT effector responses. Data was examined for associations with risk of clinical malaria for a period of 300 days. Multivariate logistic analysis incorporating age and CS response showed that cultured memory T cell responses against TRAP were associated with a significantly reduced incidence of malaria (p = 0.028). This was not seen for CS responses. Higher numbers of CD4+ CD25high T cells, potentially regulatory T cells, were associated with a significantly increased risk of clinical malaria (p = 0.039). Conclusions: These data demonstrate a role for central memory T cells in natural malarial immunity and support current vaccination strategies aimed at inducing durable protective T cell responses against the TRAP antigen. They also suggest that CD4+ CD25high T cells may negatively affect naturally acquired malarial immunity. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
10. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
- Author
-
Moody, Rhiane, Wilson, Kirsty, Flanagan, Katie L., Jaworowski, Anthony, and Plebanski, Magdalena
- Subjects
COVID-19 ,SYSTEMIC lupus erythematosus ,VIRUS diseases ,IMMUNITY ,RESPIRATORY infections ,AUTOANTIBODIES - Abstract
While first and foremost considered a respiratory infection, COVID-19 can result in complications affecting multiple organs. Immune responses in COVID-19 can both protect against the disease as well as drive it. Insights into these responses, and specifically the targets being recognised by the immune system, are of vital importance in understanding the side effects of COVID-19 and associated pathologies. The body's adaptive immunity recognises and responds against specific targets (antigens) expressed by foreign pathogens, but not usually to target self-antigens. However, if the immune system becomes dysfunctional, adaptive immune cells can react to self-antigens, which can result in autoimmune disease. Viral infections are well reported to be associated with, or exacerbate, autoimmune diseases such as multiple sclerosis (MS) and systemic lupus erythematosus (SLE). In COVID-19 patients, both new onset MS and SLE, as well as the occurrence of other autoimmune-like pathologies, have been reported. Additionally, the presence of autoantibodies, both with and without known associations to autoimmune diseases, have been found. Herein we describe the mechanisms of virally induced autoimmunity and summarise some of the emerging reports on the autoimmune-like diseases and autoreactivity that is reported to be associated with SARS-CoV-2 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Predicting memory: a prospective readout for malaria vaccines?
- Author
-
Minigo, Gabriela, Scalzo, Karen, Flanagan, Katie L., and Plebanski, Magdalena
- Subjects
- *
MALARIA , *VACCINES , *IMMUNITY , *INTERLEUKIN-2 , *INTERFERONS , *VACCINATION - Abstract
Malaria vaccines aim to induce long lasting protective immunity. Bejon and colleagues propose that levels of rapidly induced (effector memory) interleukin-2 and interferon gamma producing T-cells after vaccination with leading pre-erythrocytic stage vaccines predict the induction of resting memory responses (central memory). Herein we discuss Bejon''s findings in the context of current thinking on the generation and maintenance of T cell memory, with particular emphasis on the role of cytokines. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.